Silk Road Medical Inc. (SILK) Tops Q2 EPS by 5c

July 29, 2021 4:41 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Silk Road Medical Inc. (NASDAQ: SILK) reported Q2 EPS of ($0.31), $0.05 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.34 million.


Silk Road Medical Inc. sees Q3 2021 revenue of $104-109 million, versus the consensus of $106.04 million.

For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities